This issue's great commentary on data in @thyroidjournal For #RAS positive #thyroidnodules w/ #Bethesda III/IV #cytology, ~50% #thyroidcancer when resected, but 91% of those monitored remain unoperated over time. What should the right management be?
https://t.co/6pzxRCQyKS
This review: Dr. de Leo analyzes how #resistance to selective #RET inhibitor can develop both in RET & #MAPK pathway activation. Preclinical data show selpercatinib+trametinib can give sustained tumor response.
https://t.co/fFFncX48RQ
#thyroidcancer#RAIR@Simonedeleo86
There are #Endocrine Disrupting Chemicals (#EDC) in personal care products linked to altered #thyroid labs, #TSH#FT4#TPO. Joris Osinga reviews new data on the effects during early-to-mid #pregnancy.
https://t.co/eZ6N1EYsZE
#phthalates # polyfluoroalkyl # bisphenols